Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (81-90 of 258) with videos related to

Pageof 26
Sort By:
Clinical Transplantation|May 25, 2013
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donorsMats Remberger, Olle Ringdén, Hans Hägglund, et al.
Transplantation|April 17, 2003
Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humansGunnar Söderdahl, Lisbeth Barkholt, Patrik Hentschke, et al.
Plos One|March 9, 2023
Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host diseaseIgor Novitzky-Basso, Frida Schain, Nurgul Batyrbekova, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 22, 2026
Association of Follow-Up Chest CT Findings at 6 and 12 weeks with Survival in People with Invasive Pulmonary Aspergillosis Following Lung or Allogeneic Hematopoietic Stem Cell TransplantationRoni Bitterman, Setareh Davoudi, Laura N Walti, et al.
Clinical Transplantation|March 16, 2019
The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant diseasePetter Svenberg, Tengyu Wang, Michael Uhlin, et al.
European Journal of Haematology|November 4, 2024
Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell TransplantationNihar Desai, Auro Viswabandya, Dennis Dong Hwan Kim, et al.
Transplantation|October 14, 2006
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioningMehmet Uzunel, Mats Remberger, Darius Sairafi, et al.
Expert Review of Hematology|April 9, 2019
A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host diseaseMarcell Csanadi, Tamas Agh, Attila Tordai, et al.
Case Reports in Immunology|March 12, 2020
Posttransplantation Lymphoproliferative Disease Treated by RetransplantationIngerid Weum Abrahamsen, Bjørn Christer Grønvold, Else Marit Inderberg, et al.
Plos One|May 7, 2016
Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?Arwen Stikvoort, Mikael Sundin, Mehmet Uzunel, et al.
Pageof 26

Showing results (81-90 of 258) with videos related to

Sort By:
Pageof 26
Clinical Transplantation|May 25, 2013
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donorsMats Remberger, Olle Ringdén, Hans Hägglund, et al.
Transplantation|April 17, 2003
Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humansGunnar Söderdahl, Lisbeth Barkholt, Patrik Hentschke, et al.
Plos One|March 9, 2023
Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host diseaseIgor Novitzky-Basso, Frida Schain, Nurgul Batyrbekova, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 22, 2026
Association of Follow-Up Chest CT Findings at 6 and 12 weeks with Survival in People with Invasive Pulmonary Aspergillosis Following Lung or Allogeneic Hematopoietic Stem Cell TransplantationRoni Bitterman, Setareh Davoudi, Laura N Walti, et al.
Clinical Transplantation|March 16, 2019
The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant diseasePetter Svenberg, Tengyu Wang, Michael Uhlin, et al.
European Journal of Haematology|November 4, 2024
Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell TransplantationNihar Desai, Auro Viswabandya, Dennis Dong Hwan Kim, et al.
Transplantation|October 14, 2006
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioningMehmet Uzunel, Mats Remberger, Darius Sairafi, et al.
Expert Review of Hematology|April 9, 2019
A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host diseaseMarcell Csanadi, Tamas Agh, Attila Tordai, et al.
Case Reports in Immunology|March 12, 2020
Posttransplantation Lymphoproliferative Disease Treated by RetransplantationIngerid Weum Abrahamsen, Bjørn Christer Grønvold, Else Marit Inderberg, et al.
Plos One|May 7, 2016
Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?Arwen Stikvoort, Mikael Sundin, Mehmet Uzunel, et al.
Pageof 26